Critical Path to Public Private Partnerships

公私合作伙伴关系的关键路径

• 批准号: 10171978
• 负责人: Joseph Scheeren
• 金额: $ 139.92万
• 依托单位: CRITICAL PATH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-05 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10171978
• 关键词: Critical; Path; Public; Private; Partnerships

PROJECT SUMMARY C-Path was created in 2005 under the auspices of the Critical Path Initiative to catalyze advances in medical innovation and regulatory science by leading teams of stakeholders from academia, industry, government, and advocacy organizations and promoting the sharing of data, knowledge and expertise in order to produce sound, consensus-based science. C-Path's successes include the creation of cooperative consortia, the qualification of new drug development tools (DDTs), the endorsement of fit-for-purpose disease progression models and clinical trial simulation tools, the generation of new data standards and databases, and the creation of educational initiatives that advance regulatory science. With renewed funding C-Path will be able to continue developing Critical Path Public-Private Partnerships and advancing innovative, collaborative projects in research, education, and outreach for fostering medical product innovation, enabling the acceleration of medical product development, manufacturing, and translational therapeutics, and enhancing medical product safety.

项目摘要 C-Path于2005年在关键路径倡议的支持下创建， 医疗创新和监管科学的进步，由来自 学术界、工业界、政府和倡导组织，并促进 数据、知识和专门知识，以便产生健全的、基于共识的科学。C-Path 成功之处包括建立合作联盟， 开发工具（DDTs），认可适合目的的疾病进展模型， 临床试验模拟工具，新数据标准和数据库的生成，以及 创建促进监管科学的教育举措。随着新的资金C-Path 将能够继续发展关键路径公私合作伙伴关系， 在研究，教育和推广方面的创新，合作项目，以促进医疗 产品创新，加速医疗产品的开发、制造， 和转化疗法，并提高医疗产品的安全性。